Resource impact statement

No significant resource impact is anticipated

The NICE guideline on fever in under 5s is a partial update to NICE guideline CG160 published in May 2013 and last updated in August 2017. The evidence on assessment for Kawasaki disease has been reviewed.

We do not expect this update to have a significant impact on resources; that is:

  • the resource impact of implementing any single guideline recommendation in England will be less than £1 million per year (or £1,800 per 100,000 population) and
  • the resource impact of implementing the whole guideline in England will be less than £5 million per year (or £9,000 per 100,000 population).

Where clinical practice changes as a result of this update to the previous NICE guideline, no significant change in resource use is expected.

The updated recommendations on Kawasaki disease may result in more children being referred for assessment in secondary care. Prompt identification and treatment of children with Kawasaki disease will reduce the number of children with long-term cardiac complications and reduce long-term costs for the NHS.

Services for children under 5 with fever are commissioned by clinical commissioning groups and NHS England. Providers are primary and secondary care organisations.


This page was last updated: 07 November 2019